U.S. Names Egyptian Firm As Supplier Of Phony Avastin Cancer Drug
This article was originally published in PharmAsia News
Executive Summary
A Denmark supplier to Egypt said counterfeit drugs masquerading as Roche’s Avastin (bevacizumab) could be the source of a phony drug that surfaced in the U.S. for treating cancer.